Pacira BioSciences

PCRX

Current ValuationThe current P/E ratio is 99.10, within the reasonable range, cheaper than 46.74% of the time in the past 1 years, and the industry ranks 54/257, the industry Median -1.10.

99.1xP/E
Stock price$36.39Earnings per share$0.37

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
03774111148

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
TEVAUSTeva Pharmaceutical Industries
96.52x86.36%$48.84B
PCRXUSPacira BioSciences
99.10x302.08%$1.45B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.